Evidence map›Paper›PMID 21347128›Full record

ArticleSummit on translational bioinformatics2008

BioEMR: an integrative framework for cancer research with multiple genomic technologies.

Yu Rang Park, Yun Jung Bae, Ju Han Kim

Abstract read
In one paragraph

Article in Summit on translational bioinformatics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Development of korean rare disease knowledge base.Healthcare informatics research · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yu Rang ParkSeoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine;
Yun Jung Bae
Ju Han Kim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid development of omic technologies facilitate cancer researchers to apply multiple genomic technologies simultaneously. In fact, the complex nature of cancer biology is the reason why we need tools for data integration. Given the complexity of managing multiple technologies and dataset formats, several projects have been introduced including cancer Biomedical Informatics Grid (caGRID) and the Biomedical Research Institute Domain Group (BRIDG) with limited applicability. We introduce an object-oriented data model, Cancer Genomics Object Model (CaGe-OM) for multiple genomics data and Xperanto-CaGe, a web-based application using CaGe-OM with hybrid object-relational mapping technique. The hybrid approach uses objectrelational mapping which is extended to include dynamic structure by using Entity-Attribute-Value (EAV) model. CaGe-OM and Xperanto-CaGe are an attempt to establish a comprehensive framework for integrated storage and interpretation of clinical and multiple genomics data and to facilitate model-level integration of other newly emerging data types. A pilot implementation for the integrated clinical, histo-pathological and genomic information systems is introduced.

Identifiers

PMID21347128
PMCPMC3041523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.